Search Results - "Veth, Gerda"

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma by Venhuizen, Annemarie C., Hustinx, Willem N. M., Houte, Arend-Jan van, Veth, Gerda, Griend, René van der

Get full text

Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program by Abouyahya, Imane, Alhan, Canan, Westers, Theresia M., te Boekhorst, Peter A., Kappers-Klunne, Mies C., Coenen, Jules L., Heyning, Fenna H., Huls, Gerwin A., de Wolf, Joost T., Imholz, Alex L., Koene, Harry R., Veth, Gerda, de Kruijf, Evert-Jan F. M., Muus, Petra, Planken, Erwin V., Segeren, Christine M., Vasmel, Wies L., van der Velden, Ankie M., Velders, Gerjo A., Koedam, Jan, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A.

Get full text

Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients by WESTER, Jos P. J, HAAS, Fred J. L. M, BIESMA, Douwe H, LEUSINK, J. A, VETH, Gerda

“…Heparin-induced thrombocytopenia (HIT) is the most common form of drug-induced immune-mediated thrombocytopenia. HIT may be aggravated by life-threatening…”
Get full text

Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma by de Weerdt, O, van de Donk, N W, Veth, G, Bloem, A C, Hagenbeek, A, Lokhorst, H M

“…Multiple myeloma is an incurable disease and after several lines of chemotherapy, patients enter a phase in which no standard treatment options are available…”
Get more information

Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone by Veth, G, Meuwissen, O J, van Houwelingen, H C, Sixma, J J

“…In a randomized clinical trial the effect of subcutaneous heparin alone or in combination with dihydroergotamine or sulphinpyrazone in preventing postoperative…”
Get more information